Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations

BACKGROUND: The European Alliance of Associations for Rheumatology recommended that lipid-lowering therapy (LLT) in systemic lupus erythematosus (SLE) should follow general population guidelines. We examined the eligibility for LLT in SLE according to Systematic Coronary Risk Evaluation (SCORE), wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Drosos, George C, Konstantonis, George, Sfikakis, Petros P, Tektonidou, Maria G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923358/
https://www.ncbi.nlm.nih.gov/pubmed/36759009
http://dx.doi.org/10.1136/rmdopen-2022-002767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923358/
https://www.ncbi.nlm.nih.gov/pubmed/36759009
http://dx.doi.org/10.1136/rmdopen-2022-002767

Ejemplares similares